Mechanisms of Vascular Remodeling in Hypertension

Jay D Humphrey1

  • 1Department of Biomedical Engineering, Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut, USA.

Insights

Hypertension causes central artery stiffening, a key indicator of disease and mortality. Controlling smooth muscle and inflammation is crucial for adapting arteries to high blood pressure and preventing adverse outcomes.

Area of Science:

  • Cardiovascular Physiology
  • Biomedical Engineering
  • Pathology

Background:

  • Hypertension is linked to central artery stiffening, a predictor of various diseases and mortality.
  • Arterial stiffening involves wall remodeling driven by mechanical forces and inflammation, altering gene expression and extracellular matrix.
  • This remodeling impacts arterial function, hemodynamics, and end-organ perfusion.

Purpose of the Study:

  • To review the biomechanical mechanisms of central artery remodeling in hypertension.
  • To explore factors promoting or preventing arterial homeostasis under high blood pressure.
  • To highlight the role of vasoactive capacity and inflammation in arterial adaptation.

Main Methods:

  • Review of existing literature on hypertension, arterial mechanics, and inflammation.
  • Analysis of biomechanical stimuli and inflammatory signals in arterial wall remodeling.
  • Examination of homeostatic mechanisms and maladaptation processes.

Main Results:

  • Central artery stiffening in hypertension results from mechanical and inflammatory processes.
  • Vasoactive capacity and inflammatory burden significantly influence arterial adaptation to hypertension.
  • Maladaptation, including adventitial fibrosis, impairs arterial function and hemodynamics.

Conclusions:

  • Hypertensive arterial remodeling is a complex process influenced by mechanical and inflammatory factors.
  • Controlling smooth muscle phenotype and inflammation is vital for managing hypertensive arterial remodeling.
  • Further research into adaptive responses in medium-sized arteries may offer therapeutic insights.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
486
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
370
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
689
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.3K